Standard BioTools Inc (NAS:LAB)
$ 1.86 0.02 (1.09%) Market Cap: 688.98 Mil Enterprise Value: 318.60 Mil PE Ratio: 0 PB Ratio: 1.23 GF Score: 75/100

Fluidigm Corp at Barclays Global Healthcare Conference Transcript

Mar 11, 2020 / 08:20PM GMT
Release Date Price: $2.63 (-9.00%)
Jack Meehan
Barclays Bank PLC, Research Division - VP and Senior Research Analyst

Good afternoon, and welcome to the Barclays Virtual Health Care Conference. And our final presentation for the day, which is Fluidigm. We're joined by CEO, Chris Linthwaite. And Chris, I'll turn it over to you and let you kick it off.

Stephen Christopher Linthwaite;Jack Meehan
Fluidigm Corporation - President, CEO & Director

Thanks, Jack. As always, interesting times, and thank you very much. I want to thank you, both Barclays and you, Jack, for the introduction and the invitation, to have an opportunity to participate in the Barclays Global Health Care Conference. Next year, certainly, I hope that we can resume in South Florida and enjoy the presence and company of each other.

So I joined Fluidigm as CEO, a little over 3 years ago, and I want to walk you through first. And I think I didn't queue with you or double check, but I believe we -- do I need to tell you to advance the slides? Or will they have access to the slide show, Jack?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot